Strata Critical Medical, Inc. (SRTA) Valuation & Financial Model
Interactive Discounted Cash Flow (DCF) model for Strata Critical Medical, Inc. (US:SRTA), trading at 5.09. In 2025, Strata Critical Medical, Inc. generated $197.14 Million in revenue and -$59.92 Million in free cash flow. Explore projected intrinsic value assumptions based on institutional-grade macro metrics.
Valuation Methodology & Recent Performance
The financial model for Strata Critical Medical, Inc. is calculated using an institutional discounted cash flow (DCF) engine utilizing recent operational metrics:
- Current Price: 5.09
- Recent Revenue (2025): $197.14 Million
- Free Cash Flow (2025): -$59.92 Million
- Discount Rate (WACC): Derived using the Risk-Free Rate (e.g., 10Y Gov Bond) plus an Equity Risk Premium based on market volatility and stock price variance.
- Terminal Value: Projected using a perpetual growth model bounded by long-term macroeconomic estimates.